Literature DB >> 21658120

Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies.

U M Schaefer-Graf1, K Meitzner, H Ortega-Senovilla, K Graf, K Vetter, M Abou-Dakn, E Herrera.   

Abstract

AIMS: To evaluate the potential contribution of maternal glucose and lipids to fetal metabolic variables and growth in pregnancies with normal glucose tolerance in comparison with pregnancies with well-controlled gestational diabetes previously reported by us.
METHODS: In 190 pregnancies with normal oral glucose tolerance tests (controls), insulin, glucose and lipid components were determined in maternal and arterial cord blood serum. Birthweight and neonatal fat mass were obtained after delivery. Values were adjusted for maternal pre-pregnancy BMI, Caesarean section and gestational age. Measurements were compared with those of gestational diabetes previously reported.
RESULTS: Maternal serum glucose, triacylglycerol, free fatty acid and cholesterol levels did not differ between control pregnancies and those with gestational diabetes, whereas insulin, homeostasis model assessment and glycerol values were significantly lower in the former (2.6 vs. 5.6 μmol/l and 176 vs. 193 μmol/l, respectively). In contrast, cord blood glucose and free fatty acids were significantly lower in control pregnancies than in those with gestational diabetes (3.9 vs. 4.4 mmol/l and 80.7 vs. 137 μmol/l, respectively); the same was valid for insulin (0.03 vs. 0.05 nmol/l) and homeostasis model assessment (1.0 vs. 1.87). In control pregnancies, maternal serum glucose, free fatty acids and glycerol correlated with those in cord blood, but not with neonatal weight and fat mass, as seen for free fatty acids in those with gestational diabetes. The negative correlation between cord blood triacylglycerols and neonatal weight or fat mass previously reported in gestational diabetes could not be confirmed in control pregnancies, where all fetal lipids showed a positive correlation to neonatal anthropometrics.
CONCLUSION: In normal pregnancies, in contrast to those with gestational diabetes, maternal lipids do not influence neonatal weight. Similar levels of maternal lipids in pregnancies with gestational diabetes and control pregnancies, but higher free fatty acids in the cord blood of those with gestational diabetes, indicate their enhanced placental transport and/or enhanced lipolysis as a result of decreased fetal insulin responsiveness.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658120     DOI: 10.1111/j.1464-5491.2011.03346.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  37 in total

Review 1.  Maternal cholesterol levels during gestation: boon or bane for the offspring?

Authors:  V S Jayalekshmi; Surya Ramachandran
Journal:  Mol Cell Biochem       Date:  2020-09-22       Impact factor: 3.396

Review 2.  Developmental overnutrition and obesity and type 2 diabetes in offspring.

Authors:  Wei Perng; Emily Oken; Dana Dabelea
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

Review 3.  Developmental origins of NAFLD: a womb with a clue.

Authors:  Stephanie R Wesolowski; Karim C El Kasmi; Karen R Jonscher; Jacob E Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-10-26       Impact factor: 46.802

4.  Maternal fuels and metabolic measures during pregnancy and neonatal body composition: the healthy start study.

Authors:  Tessa L Crume; Allison L Shapiro; John T Brinton; Deborah H Glueck; Mercedes Martinez; Mary Kohn; Curtis Harrod; Jacob E Friedman; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2015-01-09       Impact factor: 5.958

Review 5.  Implications of Lipids in Neonatal Body Weight and Fat Mass in Gestational Diabetic Mothers and Non-Diabetic Controls.

Authors:  Emilio Herrera; Henar Ortega-Senovilla
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

Review 6.  Intergenerational transmission of the effects of maternal exposure to childhood maltreatment on offspring obesity risk: A fetal programming perspective.

Authors:  Karen L Lindsay; Sonja Entringer; Claudia Buss; Pathik D Wadhwa
Journal:  Psychoneuroendocrinology       Date:  2020-03-23       Impact factor: 4.905

7.  Pregnant women with gestational diabetes and with well controlled glucose levels have decreased concentrations of individual fatty acids in maternal and cord serum.

Authors:  Henar Ortega-Senovilla; Ute Schaefer-Graf; Emilio Herrera
Journal:  Diabetologia       Date:  2019-12-12       Impact factor: 10.122

8.  Newborn body fat: associations with maternal metabolic state and placental size.

Authors:  Camilla M Friis; Elisabeth Qvigstad; Marie Cecilie Paasche Roland; Kristin Godang; Nanna Voldner; Jens Bollerslev; Tore Henriksen
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatment.

Authors:  Helen L Barrett; Kathryn L Gatford; Candice M Houda; Miles J De Blasio; H David McIntyre; Leonie K Callaway; Marloes Dekker Nitert; Suzette Coat; Julie A Owens; William M Hague; Janet A Rowan
Journal:  Diabetes Care       Date:  2012-10-09       Impact factor: 19.112

10.  Determinants of maternal triglycerides in women with gestational diabetes mellitus in the Metformin in Gestational Diabetes (MiG) study.

Authors:  Helen L Barrett; Marloes Dekker Nitert; Lee Jones; Peter O'Rourke; Karin Lust; Kathryn L Gatford; Miles J De Blasio; Suzette Coat; Julie A Owens; William M Hague; H David McIntyre; Leonie Callaway; Janet Rowan
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.